Restamax Plc: RESTAMAX TO BUY A MAJORITY OF STAFF INVEST

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 8, 2014 at 3:15 AM

Restamax Plc: RESTAMAX TO BUY A MAJORITY OF STAFF INVEST GROUP'S LABOUR HIRE SERVICE OPERATIONS

Restamax Plc STOCK EXCHANGE RELEASE 8 JULY 2014, 10:00 am RESTAMAX TO BUY A MAJORITY OF STAFF INVEST GROUP'S LABOUR HIRE SERVICE OPERATIONS Restamax Plc and Staff Invest Oy have agreed on a corporate acquisition ('Corporate Acquisition'). The realisation of the Corporate Acquisition is subject to the confirmation and approval of the Restamax Plc Extraordinary General Meeting to be summoned later on. Restamax and Staff Invest have signed a contract of sale by which Restamax or its wholly-owned subsidiary will purchase the Staff Invest Oy labour hire service operations and also certain shares of Staff Invest Oy's subsidiaries that provide labour hire services. The object of the Corporate Acquisition comprises about 75 per cent of all Staff Invest group's business operations. Staff Invest group's turnover in the financial period which ended on 31 July 2013 was approximately MEUR 18.0, EBITDA MEUR 2.2 and the income of the financial period MEUR 1.2. The estimated turnover of the object of acquisition in the financial period ending on 31 July 2014 is approximately MEUR 13.4, with an estimated EBITDA of approximately MEUR 1.8. Restamax's share of the present financial period's turnover is approximately MEUR 8. The object of acquisition has approximately 100 corporate clients, most of which operate in the restaurant industry, and its stock of contracts in the field of labour hire services is worth approximately MEUR 33.5 (30 June 2014). "Restamax has solid competence in the restaurant business and also plenty of experience in part-time employment relationships that are typical in the industry. Through this Corporate Acquisition, we can ensure the availability of staff now and in the future and strengthen the growth of the restaurant company. Restamax is Staff Invest's largest client. Through this transaction, the profit margin of hired labour working in Restamax restaurants remains within the group," says Markku Virtanen, CEO of Restamax Plc. The majority of Staff Invest Oy's shareholders are parties related to Restamax Plc, which makes the Corporate Acquisition a related party transaction. The property of Staff Invest Oy is divided as follows: Wawe Capital Oy 45%, Avemari Oy 27.5%, Eiran Ravintolatoimi Oy 11.25%, JV-Staff Oy 11.25% and Mr Max Oy 5%. Of the shareholders, Wawe Capital Oy is controlled by the spouse of Timo Laine who is the Chair of the Board of Directors of Restamax Plc; Mr Max Oy is jointly owned by Timo Laine and Restamax Plc board member Mikko Aartio; the chief shareholder of Eiran Ravintolatoimi Oy is Mikko Aartio while Timo Laine from Avemari Oy owns half the company through Almalex Capital Oy, which he controls. Restamax will pay a total sum of approximately MEUR 7.7 of the Staff Invest labour hire services and the shares of subsidiaries included in the sale. The sum will be adjusted with the difference of the current assets and borrowed funds of the subsidiaries in accordance with the financial statements of 31 July 2014 ('Purchase price'). The purchase price will be paid in cash. Approximately MEUR 7.0 of the purchase price will be paid on the date of transferring operations and ownership, and MEUR 0.7 will be paid in 24 equal monthly instalments after the transfer of operations. The final purchase price will be determined based on financial statements issued on 31 July 2014 no later than on 31 December 2014, by which date the difference between the current assets and borrowed funds of the companies will also be paid to the vendor in accordance with the companies' financial statements of 31 July 2014. The Corporate Acquisition is bank-funded within the framework of Restamax's current funding limits. If the Extraordinary General Meeting approves and confirms the Corporate Acquisition, the operations and ownership will be transferred on 1 August 2014, and the operations will from then on be included in the Restamax Group and reported as a separate segment. Restamax is planning to summon an Extraordinary General Meeting on 29 July 2014. Notice of the Extraordinary General Meeting and additional information on the disclosed Corporate Acquisition will be published today at 12:00 noon. Additional information: Markku Virtanen, Restamax Plc, CEO, tel. +358 400 836 477 Jarno Suominen, Restamax Plc, CFO, tel. +358 40 721 5655 Distribution: NASDAQ OMX Helsinki Major media www.restamax.fi Restamax Plc is a Finnish restaurant business group established in 1996. The company has continued to grow steadily throughout its history. The group companies include approximately 80 restaurants, cafés, pubs and nightclubs all over Finland. Well-known restaurant concepts of the group include, among others, Ristorante Bella Roma, Gringos Locos, Viihdemaailma Ilona, Daddy's Diner and Stefan's Steakhouse. Wayne's Coffee is also a part of the company's portfolio. Restamax Plc employs approximately 900 people, the Group's pro forma turnover in 2013 was MEUR 87.0 and EBITDA MEUR 13.3. www.restamax.fi. [HUG#1817431]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...